NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Ou.

I saw this with Medarex a few years back. They had big news about patients with tumors that had shrunk, but it wasn't trial data. CNBC carried the story pre-market…. The stock rallied briefly and then ended up only slighty. It was a great buying opportunity and the company was eventually bought out. But I was puzzled why the stock didn't move more. I still don't understand it. I know we need more data (from both trials) to get NWBO to take off, but I added today - both pre-market and in the regular trading. -- Ou

Ou, I looked up the treatment price for Medarex treatment back then, it exceeded Provenge. Would I be correct in assuming Medarex did not posses the institutional groundwork back then that NWBO has now? Was the Medarex treatment only applicable to a very limited number of cancer applications? Did Medarex have the manufacturing, distribution, governmental H.E. and reimbursement advantages NWBO now possesses? Etc.

I only ask this because I do not know.